Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed, replacing the previous wording; revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:17:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding operating status banner that informed users about potential delays and provided links to cc.nih.gov and opm.gov.
    Difference
    0.3%
    Check dated 2025-11-18T06:43:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The update shows a newer last update date and minor formatting changes; core study details, eligibility criteria, and enrollment remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T18:34:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page updated how it displays the last update timestamp: replaced 'Last Update Posted' with 'Last Update Posted (Estimated)'.
    Difference
    0.0%
    Check dated 2025-10-13T06:59:48.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Core content and versioning updated: added a government-operating-status notice and new version/date metadata; removed older dates and revision v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:28:40.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Upgrade version from v3.0.2 to v3.1.0 with an added update marker; no substantive content or critical data changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T01:19:24.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.